Hepatic arterial infusion of GEMOX plus systemic gemcitabine chemotherapy combined with lenvatinib and PD-1 inhibitor in large unresectable intrahepatic cholangiocarcinoma
Article in International Immunopharmacology (August 2024)
The most recent citing publications are shown below. View all 10 publications that cite this research output on Dimensions.
Ex vivo liver resection and auto-transplantation and special systemic therapy in perihilar cholangiocarcinoma treatment
Article in World Journal of Gastrointestinal Surgery (March 2024)
PD-L1 inhibitor plus gemcitabine and cisplatin therapy followed by conversion surgery for initially unresectable advanced gallbladder cancer
Article in BMJ Case Reports (December 2023)